{"resourceType":"Condition","id":"47094","meta":{"versionId":"2","lastUpdated":"2022-12-19T19:51:06.698+01:00","source":"#Mv5CtXhaazk9xXqH","profile":["http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp"]},"language":"ES","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/condition-assertedDate","valueDateTime":"2021-04-17"},{"url":"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-histology-morphology-behavior","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"9896/3","display":"Leucemia mieloide aguda, LMA1(CBF- alfa)/ETO  ( maligno ) "}]}}],"bodySite":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"C42.1"}]}],"subject":{"reference":"Patient/47093"},"evidence":[{"code":[{"coding":[{"system":"http://snomed.info/sct","code":"106221001","display":"Evidencia de Marcadores Genéticos"}],"text":"t(8;21), pérdida de cromosoma Y, AML1/ETO +; RUNX1/RUNX1T1 positivo, FLT3 mutación D835, mutación CKIT exón 8 - , exón 17 +"}]}]}
